πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 12 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8815246

Fc receptor binding proteins

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8449884

Clotting factor-fc chimeric proteins to treat hemophilia

Syntonix Pharmaceuticals, Inc. Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8329182

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8293707

Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8273351

Fc receptor binding proteins

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8101186

Peptides that block the binding of IgG to FcRn

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7862820

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7820162

Methods for chemically synthesizing immunoglobulin chimeric proteins

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7601516

Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment o

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7404956

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7381408

Methods for chemically synthesizing immunoglobulin chimeric proteins

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7348004

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted